martes, 3 de octubre de 2023

Global HIV control: is the glass half empty or half full? Nachega et al.

https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(23)00150-9/fulltext Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial Marzinke et al. https://www.thelancet.com/journals/lanhiv/home

No hay comentarios:

Publicar un comentario